The 22 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 64.24, with a high estimate of 77.12 and a low estimate of 42.06. The median estimate represents a +22.12% increase from the last price of 52.60.
The current consensus among 26 polled investment analysts is to Buy stock in AstraZeneca PLC. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.54
Reporting Date Feb 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.